Tethered Enzyme Technologies, Inc.
Tethered Enzyme Technologies, Inc. is a clinical-stage platform nanomedicine company focused on enabling actionable insights for high-consequence disease decision-making.
Tethered Enzyme Technologies, Inc. is a clinical-stage platform nanomedicine company focused on enabling actionable insights for high-consequence disease decision-making.
MedExplain is designed to meet the needs of patients and their loved ones who want plain facts about drugs, health, and disease. It is a publicly available resource designed to provide engaging, easily understood, and well-researched articles by doctors for people who want to know more about health, medicines, and diseases.
REEgen is reimagining the global rare earth supply by replacing the most harmful production steps with clean microbial processes, securing these critical elements for a future of unbounded, widespread renewable energy. Other applications include screens of smartphones, computers, flat-panel televisions, the motors of computer drives, batteries of hybrid and electric cars, and new generation light bulbs.
Forte Protein uses a plant-based technology to produce a broad spectrum of meat, fish, and dairy proteins without the need for animals eliminating the carbon footprint involved in animal agriculture.
A discovery through early clinical phase pharmaceutical company, Ratio Therapeutics employs a suite of innovative technologies to develop best-in-class targeted radiotherapeutics for the treatment of cancers.
KanduPay, Inc. is a dynamic cryptocurrency exchange, e-Wallet, and remittance solution that facilitates and eases the exchange of fiat & digital currencies, financial transactions, and wallet services across market channels for its platform users supporting major currencies across the globe (KanduPay.com).
XenImmune Therapeutics is developing a novel antibody-enzyme fusion to target tumors and trigger the robust immune response known as hyper-acute rejection.
Pelex is a digital health platform for pelvic floor disorders built on a proprietary connected medical device. The goal of the company is to revolutionize the patient experience by bringing diagnosis AND treatment of pelvic floor disorders out of the clinic and into the home.
Export control for shipping research and clinical materials is complex and fraught with human error. Onasys leverages industry best practice and regulations to ensure your organization is productive, compliant, and safe. Onasys was founded by industry experts at Weill Cornell Medicine and Fitzroy Health.